These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 20213343)

  • 1. Cyclic GMP and nitric oxide synthase in aging and Alzheimer's disease.
    Domek-Łopacińska KU; Strosznajder JB
    Mol Neurobiol; 2010 Jun; 41(2-3):129-37. PubMed ID: 20213343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating nitric oxide signaling in the CNS for Alzheimer's disease therapy.
    Zhihui Q
    Future Med Chem; 2013 Aug; 5(12):1451-68. PubMed ID: 23919554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum. Effects of amyloid beta peptide.
    Chalimoniuk M; Strosznajder JB
    Mol Chem Neuropathol; 1998; 35(1-3):77-95. PubMed ID: 10343972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
    de Vente J; Markerink-van Ittersum M; Vles JS
    J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of nitric oxide-cyclic GMP signalling in CNS cells and its possible regulation by cyclic GMP.
    Wykes V; Bellamy TC; Garthwaite J
    J Neurochem; 2002 Oct; 83(1):37-47. PubMed ID: 12358727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase type 2 and the homeostasis of cyclic GMP in living thalamic neurons.
    Hepp R; Tricoire L; Hu E; Gervasi N; Paupardin-Tritsch D; Lambolez B; Vincent P
    J Neurochem; 2007 Sep; 102(6):1875-1886. PubMed ID: 17561940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide-cyclic GMP pathway with some emphasis on cavernosal contractility.
    Ghalayini IF
    Int J Impot Res; 2004 Dec; 16(6):459-69. PubMed ID: 15229623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide synthase and cyclic GMP signaling in cardiac myocytes: from contractility to remodeling.
    Hammond J; Balligand JL
    J Mol Cell Cardiol; 2012 Feb; 52(2):330-40. PubMed ID: 21843527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homogeneous single-label cGMP detection platform for the functional study of nitric oxide-sensitive (soluble) guanylyl cyclases and cGMP-specific phosphodiesterases.
    Kopra K; Sharina I; Martin E; Härmä H
    Sci Rep; 2020 Oct; 10(1):17469. PubMed ID: 33060787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme activities of the nitric oxide-cGMP pathway in corpus cavernosum isolated from middle-aged rats.
    Hosogai N; Takakura S; Manda T; Mutoh S
    Eur J Pharmacol; 2003 Jul; 473(1):65-70. PubMed ID: 12877939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases.
    Dupont LL; Glynos C; Bracke KR; Brouckaert P; Brusselle GG
    Pulm Pharmacol Ther; 2014 Oct; 29(1):1-6. PubMed ID: 25043200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting NO/cGMP Signaling in the CNS for Neurodegeneration and Alzheimer's Disease.
    Ben Aissa M; Lee SH; Bennett BM; Thatcher GR
    Curr Med Chem; 2016; 23(24):2770-2788. PubMed ID: 27776476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3',5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study.
    Lee NP; Cheng CY
    Endocrinology; 2003 Jul; 144(7):3114-29. PubMed ID: 12810568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways.
    Padovan-Neto FE; Sammut S; Chakroborty S; Dec AM; Threlfell S; Campbell PW; Mudrakola V; Harms JF; Schmidt CJ; West AR
    J Neurosci; 2015 Apr; 35(14):5781-91. PubMed ID: 25855188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal AMPA- and NMDA-induced cGMP signals are mainly generated by NO-GC2 and are under tight control by PDEs 1 and 2.
    Giesen J; Mergia E; Koesling D; Russwurm M
    Eur J Neurosci; 2022 Jan; 55(1):18-31. PubMed ID: 34902209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.
    Hussain MB; Hobbs AJ; MacAllister RJ
    Br J Pharmacol; 1999 Nov; 128(5):1082-8. PubMed ID: 10556946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. sGC-cGMP signaling: target for anticancer therapy.
    Bian K; Murad F
    Adv Exp Med Biol; 2014; 814():5-13. PubMed ID: 25015797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formalin injection causes a coordinated spinal cord CO/NO-cGMP signaling system response.
    Shi X; Li X; Clark JD
    Mol Pain; 2005 Nov; 1():33. PubMed ID: 16297238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic GMP metabolism and its role in brain physiology.
    Domek-Łopacińska K; Strosznajder JB
    J Physiol Pharmacol; 2005 Mar; 56 Suppl 2():15-34. PubMed ID: 16077188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endurance training upregulates the nitric oxide/soluble guanylyl cyclase/cyclic guanosine 3',5'-monophosphate pathway in the striatum, midbrain and cerebellum of male rats.
    Chalimoniuk M; Chrapusta SJ; Lukačova N; Langfort J
    Brain Res; 2015 Aug; 1618():29-40. PubMed ID: 26006108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.